Ocular Hypertension Global Clinical Trials Review 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: Santen Pharma, Aerie Pharma, Valeant Pharma - Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Ocular Hypertension Global Clinical Trials Review, H1, 2016" clinical trials to their offering.

The clinical trial report, Ocular Hypertension Global Clinical Trials Review, H1, 2016" provides an overview of Ocular Hypertension clinical trials scenario. This report provides top line data relating to the clinical trials on Ocular Hypertension. The report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. The report also provides prominent drugs for in-progress trials (based on number of ongoing trials).

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Key Topics Covered:

• The report provides a snapshot of the global clinical trials landscape
• The report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
• The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
• The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

Benefits of this Report:

• Assists in formulating key business strategies with regards to investment
• Helps in identifying prominent locations for conducting clinical trials which saves time and cost
• Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
• Supports understanding of trials count and enrollment trends by country in global therapeutics market
• Facilitates clinical trial assessment of the indication on a global, regional and country level

Companies Mentioned:

• Novartis AG
• Allergan Plc
• Pfizer Inc.
• Santen Pharmaceutical Co., Ltd.
• Aerie Pharmaceuticals, Inc.
• Valeant Pharmaceuticals International, Inc.
• Merck & Co., Inc.
• Kowa Company, Ltd.
• Mati Therapeutics Inc.
• QLT Inc.

For more information visit http://www.researchandmarkets.com/research/j92g6v/ocular